MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Implants / Maquet acquires LAAx and its TigerPaw II heart implant

Maquet acquires LAAx and its TigerPaw II heart implant

May 21, 2013 By Sony Salzman Leave a Comment

Maquet

Getinge (PINK:GETI B) subsidiary Maquet Cardiovascular said it bought LAAx Inc and its TigerPaw II heart implant for an undisclosed amount.

The TigerPaw II device is designed to occlude the heart’s left atrial appendage to treat post-operative stroke after open heart surgery for atrial fibrillation. Maquet said the soft silicone device "conforms to its shape and thickness, minimizing the risk of tissue damage and accidental bleeding," according to a press release.

The device already has clearance in the U.S. and the European Union, where it’s slated to go on the market this month and in June, respectively.

Maquet said TigerPaw II represents the first in a line of products for patients with atrial fibrillation.

"We believe TigerPaw II will be a best-in-class device for reliable ligation of the left atrial appendage, potentially mitigating post-operative stroke and its associated costs in patients with atrial fibrillation undergoing cardiac surgery,” Peter Hinchliff, Maquet CEO said in prepared remarks.

“Atrial fibrillation affects millions of people worldwide, and the Centers for Disease Control and Prevention expect that number to climb significantly in the years to come. We believe TigerPaw II will play an important role for our customers as they treat more and more patients with atrial fibrillation.” 

Maquet racked up a win for another of its devices designed to close artery incisions for catheters after the FDA cleared its Air-Band radial compression device for the U.S. market last month. The company was also recently slammed with a Class I FDA recall for malfunctioning battery units in ventilators.

Filed Under: Implants, Mergers & Acquisitions, News Well Tagged With: Getinge, LAAx Inc., Maquet Cardiovascular LLC

In case you missed it

  • FDA clears augmented glenoids for Shoulder Innovations system
  • McKesson names new chief information and technology officer
  • Imperative Care raises $85m
  • CMR Surgical appoints new CEO
  • Peregrine Ventures raises $115m
  • Roche wins CE Mark for blood glucose reading smartphone app
  • Cantel Medical beats The Street in Q1 results
  • FDA details framework for abbreviated 510(k) medical device review pathway
  • Drug or device? FDA loses this argument for now
  • Aptar wins FDA clearance for ready-to-use seizure treatment device
  • Aurora Bio touts PET radiotracer data
  • Medical device excise tax would reduce R&D spending, report says
  • Proteus Digital Health restructuring amid reported funding woes
  • GE Healthcare partnering on regenerative tissue manufacturing
  • Schiller issues field safety notice for Tempus LS defibrillators
  • Report: 3M may sell off its drug-delivery business for $1 billion
  • Abbott issues field safety notice for Heartmate 3 LVAS power unit

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS